Mr. Pink's Picks: selected event-driven value investments Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Mr. Pink's Picks: selected event-driven value investments

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mr. Pink who wrote (3445)	10/2/1998 11:15:00 PM
From: TRIIBoy	of 18998

Mr. Pink, Your loyal servant has brought you a sacrificial company to your altar, I hope it is worth your pinkishness... Immunex (NASDAQ: IMNX) 1)in the next two to three weeks estimates will go down from positive EPS of anywhere from $0.50 to $0.90 to losses. 2)Enbrel drug, which is the big drug company is basing current fortunes on, got a harsh review in FDA review panel in September, very restrictive labelling 3)company needs financing, analysts keeping it above water for juicy secondary 4)FDA has manufacturing concerns, possibility of a delay in November. 5)market cap does not justify the puny 15% margins it could get from Enbrel

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next